Girolamo Mattioli

Girolamo Mattioli

Auto-generated profile, based on publicly available information

Girolamo Mattioli

Department of Pediatric Surgery, IRCCS Istituto Giannina Gaslini, Genova, Italy

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in The Lancet
Verified
Journal Article
Open access
MMMary Ellen McCann
Mary Ellen McCann
JGJurgen C de Graaff
Jurgen C de Graaff
LDLiam Dorris
Liam Dorris
NDNicola Disma
Nicola Disma
DWDavinia Withington
Davinia Withington
RWRobert Williams
Robert Williams
In laboratory animals, exposure to most general anaesthetics leads to neurotoxicity manifested by neuronal cell death and abnormal behaviour and cognition. Some large human cohort studies have shown an association between general anaesthesia at a young age and subsequent neurodevelopmental deficits, but these studies are prone to bias. Others have found no evidence for an association. We aimed to establish whether general anaesthesia in early infancy affects neurodevelopmental outcomes. In this international, assessor-masked, equivalence, randomised, controlled trial conducted at 28 hospitals in Australia, Italy, the USA, the UK, Canada, the Netherlands, and New Zealand, we recruited infants of less than 60 weeks' postmenstrual age who were born at more than 26 weeks' gestation and were undergoing inguinal herniorrhaphy, without previous exposure to general anaesthesia or risk factors for neurological injury. Patients were randomly assigned (1:1) by use of a web-based randomisation service to receive either awake-regional anaesthetic or sevoflurane-based general anaesthetic. Anaesthetists were aware of group allocation, but individuals administering the neurodevelopmental assessments were not. Parents were informed of their infants group allocation upon request, but were told to mask this information from assessors. The primary outcome measure was full-scale intelligence quotient (FSIQ) on the Wechsler Preschool and Primary Scale of Intelligence, third edition (WPPSI-III), at 5 years of age. The primary analysis was done on a per-protocol basis, adjusted for gestational age at birth and country, with multiple imputation used to account for missing data. An intention-to-treat analysis was also done. A difference in means of 5 points was predefined as the clinical equivalence margin. This completed trial is registered with ANZCTR, number ACTRN12606000441516, and ClinicalTrials.gov, number NCT00756600. Between Feb 9, 2007, and Jan 31, 2013, 4023 infants were screened and 722 were randomly allocated: 363 (50%) to the awake-regional anaesthesia group and 359 (50%) to the general anaesthesia group. There were 74 protocol violations in the awake-regional anaesthesia group and two in the general anaesthesia group. Primary outcome data for the per-protocol analysis were obtained from 205 children in the awake-regional anaesthesia group and 242 in the general anaesthesia group. The median duration of general anaesthesia was 54 min (IQR 41-70). The mean FSIQ score was 99·08 (SD 18·35) in the awake-regional anaesthesia group and 98·97 (19·66) in the general anaesthesia group, with a difference in means (awake-regional anaesthesia minus general anaesthesia) of 0·23 (95% CI -2·59 to 3·06), providing strong evidence of equivalence. The results of the intention-to-treat analysis were similar to those of the per-protocol analysis. Slightly less than 1 h of general anaesthesia in early infancy does not alter neurodevelopmental outcome at age 5 years compared with awake-regional anaesthesia in a predominantly male study population. US National Institutes of Health, US Food and Drug Administration, Thrasher Research Fund, Australian National Health and Medical Research Council, Health Technologies Assessment-National Institute for Health Research (UK), Australian and New Zealand College of Anaesthetists, Murdoch Children's Research Institute, Canadian Institutes of Health Research, Canadian Anesthesiologists Society, Pfizer Canada, Italian Ministry of Health, Fonds NutsOhra, UK Clinical Research Network, Perth Children's Hospital Foundation, the Stan Perron Charitable Trust, and the Callahan Estate.

1 September 2009 in Kidney International
Verified
Journal Article
Closed access
SSSimone Sanna-Cherchi
Simone Sanna-Cherchi
PRPietro Ravani
Pietro Ravani
VCValentina Corbani
Valentina Corbani
SPStefano Parodi
Stefano Parodi
RHRiccardo Haupt
Riccardo Haupt
Gian Marco GhiggeriGian Marco Ghiggeri
Gian Marco Ghiggeri

1 November 2021 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
SASalvatore Arena
Salvatore Arena
Di Fabrizio DonatellaDi Fabrizio Donatella
Di Fabrizio Donatella
PIPietro Impellizzeri
Pietro Impellizzeri
PGPaolo Gandullia
Paolo Gandullia
GMGirolamo Mattioli
Girolamo Mattioli
CRcarmelo romeo
carmelo romeo

1 March 1998 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
GIGiorgio Ivani
Giorgio Ivani
NMNadia Mereto
Nadia Mereto
ELElisabetta Lampugnani
Elisabetta Lampugnani
PNPasquale De Negri
Pasquale De Negri
MTMichele Torre
Michele Torre
PLPer Lönnqvist
Per Lönnqvist

21 January 2011 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
APAlessio Pini Prato
Alessio Pini Prato
VRValentina Rossi
Valentina Rossi
SAStefano Avanzini
Stefano Avanzini
GMGirolamo Mattioli
Girolamo Mattioli
NDNicola Disma
Nicola Disma
VJVincenzo Jasonni
Vincenzo Jasonni

25 April 2017 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
SAStefano Avanzini
Stefano Avanzini
Luca PioLuca Pio
Luca Pio
GEGiovanni Erminio
Giovanni Erminio
CGClaudio Granata
Claudio Granata
KHKeith Holmes
Keith Holmes
SSSabine Sarnacki
Sabine Sarnacki